Related references
Note: Only part of the references are listed.Cyclin-Dependent kinase 5 targeting prevents beta-Amyloid aggregation involving glycogen synthase kinase 3 beta and phosphatases
John Fredy Castro-Alvarez et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2015)
Inhibition of amyloid-β plaque formation by α-synuclein
Teresa Bachhuber et al.
NATURE MEDICINE (2015)
Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils
Atsushi Tsujimura et al.
NEUROBIOLOGY OF DISEASE (2015)
Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution
C. Vergara et al.
MOLECULAR NEUROBIOLOGY (2015)
Epigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils
Liuhong Li et al.
EXPERIMENTAL BRAIN RESEARCH (2015)
Dual roles for autophagy: Degradation and secretion of Alzheimer's disease Aβ peptide
Per Nilsson et al.
BIOESSAYS (2014)
Extracellular oligomers of alpha-synuclein induce Parkin modifications and dopaminergic PC12 cell death
A. Lenkiewicz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Sphingosine kinases modulate the secretion of amyloid β precursor protein from SH-SY5Y neuroblastoma cells: the role of α-synuclein
Henryk Jesko et al.
FOLIA NEUROPATHOLOGICA (2014)
A critical analysis of the 'amyloid cascade hypothesis'
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2014)
SNJ-1945, a Calpain inhibitor, protects SH-SY5Y cells against MPP+ and rotenone
Varduhi H. Knaryan et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Phosphorylation of Synapsin I by Cyclin-Dependent Kinase-5 Sets the Ratio between the Resting and Recycling Pools of Synaptic Vesicles at Hippocampal Synapses
Anne M. J. Verstegen et al.
JOURNAL OF NEUROSCIENCE (2014)
Differential Effects of Synaptic and Extrasynaptic NMDA Receptors on Aβ-Induced Nitric Oxide Production in Cerebrocortical Neurons
Elena Molokanova et al.
JOURNAL OF NEUROSCIENCE (2014)
Parkin Plays a Role in Sporadic Parkinson's Disease
Ted M. Dawson et al.
NEURODEGENERATIVE DISEASES (2014)
Memory Enhancement by Targeting Cdk5 Regulation of NR2B
Florian Plattner et al.
NEURON (2014)
Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
Magdalena Gassowska et al.
PLOS ONE (2014)
CDK5 activator protein p25 preferentially binds and activates GSK3β
Hei-Man Chow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer's disease
K. Peter Giese
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Alzheimer's Amyloid-β Oligomers Rescue Cellular Prion Protein Induced Tau Reduction via the Fyn Pathway
Rong-Jie Chen et al.
ACS CHEMICAL NEUROSCIENCE (2013)
A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
Varsha Shukla et al.
FASEB JOURNAL (2013)
Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro
Grzegorz A. Czapski et al.
FEBS LETTERS (2013)
Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5
Hailong Hou et al.
JOURNAL OF CELL BIOLOGY (2013)
Lysosomal impairment in Parkinson's disease
Benjamin Dehay et al.
MOVEMENT DISORDERS (2013)
5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5
Jin Chu et al.
NEUROBIOLOGY OF AGING (2013)
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Joohyun Park et al.
NEUROBIOLOGY OF DISEASE (2013)
Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration
Anna Wilkaniec et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Reciprocal Induction Between alpha-Synuclein and beta-Amyloid in Adult Rat Neurons
Shohreh Majd et al.
NEUROTOXICITY RESEARCH (2013)
The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models
Hiroyasu Sato et al.
REVIEWS IN THE NEUROSCIENCES (2013)
Tangles, toxicity, and tau secretion in AD - new approaches to a vexing problem
Kerry L. Gendreau et al.
FRONTIERS IN NEUROLOGY (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease
Saranya Jayapalan et al.
BIOINFORMATION (2013)
Calpain Inhibitor A-705253 Mitigates Alzheimer's Disease-Like Pathology and Cognitive Decline in Aged 3xTgAD Mice
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cdk5 Protein Inhibition and Aβ42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism IMPLICATIONS OF CDK5 AS A THERAPEUTIC TARGET FOR ALZHEIMER DISEASE
Katherine R. Sadleir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Soluble A ss oligomer production and toxicity
Megan E. Larson et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Yoshihisa Watanabe et al.
PLOS ONE (2012)
S-nitrosylation of Cdk5 Potential implications in amyloid-β-related neurotoxicity in Alzheimer disease
Jing Qu et al.
PRION (2012)
Tau, prions and A beta: the triad of neurodegeneration
Lilla Reiniger et al.
ACTA NEUROPATHOLOGICA (2011)
Cyclin-Dependent Kinase 5 Activator p25 Is Generated During Memory Formation and Is Reduced at an Early Stage in Alzheimer's Disease
Olivia Engmann et al.
BIOLOGICAL PSYCHIATRY (2011)
Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease
Tiffany Kaul et al.
BMC NEUROSCIENCE (2011)
Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease
P. Hemachandra Reddy
BRAIN RESEARCH (2011)
Stimulatory effect of α-synuclein on the tau-phosphorylation by GSK-3ß
Fumitaka Kawakami et al.
FEBS JOURNAL (2011)
Alterations of Cyclin dependent kinase 5 expression and phosphorylation in Amyloid precursor protein (APP)-transfected PC12 cells
Grzegorz A. Czapski et al.
FEBS LETTERS (2011)
Nuclear Tau, a Key Player in Neuronal DNA Protection
Audrey Sultan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Early Growth Response 1 (Egr-1) Regulates Phosphorylation of Microtubule-associated Protein Tau in Mammalian Brain
Yifan Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Synaptic Deficits Are Rescued in the p25/Cdk5 Model of Neurodegeneration by the Reduction of β-Secretase (BACE1)
Paola Giusti-Rodriguez et al.
JOURNAL OF NEUROSCIENCE (2011)
Cyclin-Dependent Kinase 5 Regulates PSD-95 Ubiquitination in Neurons
Michael J. Bianchetta et al.
JOURNAL OF NEUROSCIENCE (2011)
Inhibition of Cyclin-Dependent Kinase 5 but Not of Glycogen Synthase Kinase 3-β Prevents Neurite Retraction and Tau Hyperphosphorylation Caused by Secretable Products of Human T-Cell Leukemia Virus Type I-Infected Lymphocytes
Horacio Maldonado et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death
Kuei-Hua Chang et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease
Alan S. L. Wong et al.
NATURE CELL BIOLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice
Gonzalo I. Cancino et al.
NEUROBIOLOGY OF AGING (2011)
A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5)
Anna Kazmierczak et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Lydia Alvarez-Erviti et al.
NEUROSCIENCE RESEARCH (2011)
CDK5 Is Essential for Soluble Amyloid β-Induced Degradation of GKAP and Remodeling of the Synaptic Actin Cytoskeleton
Francesco Roselli et al.
PLOS ONE (2011)
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by β-amyloid peptide
Jing Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
L. Crews et al.
CELL DEATH & DISEASE (2011)
Neurodegeneration in an Aβ-induced model of Alzheimer's disease: the role of Cdk5
Joao P. Lopes et al.
AGING CELL (2010)
Neurotoxicity of beta-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis
Masahiro Kawahara
CURRENT PHARMACEUTICAL DESIGN (2010)
A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation
Ya-Li Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Silencing of CDK5 Reduces Neurofibrillary Tangles in Transgenic Alzheimer's Mice
Diego Piedrahita et al.
JOURNAL OF NEUROSCIENCE (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
The Role of Parkin in Familial and Sporadic Parkinson's Disease
Ted M. Dawson et al.
MOVEMENT DISORDERS (2010)
A role for p53 in the beta-amyloid-mediated regulation of the lysosomal system
Marie P. Fogarty et al.
NEUROBIOLOGY OF AGING (2010)
CDK5 Serves as a Major Control Point in Neurotransmitter Release
Sung Hyun Kim et al.
NEURON (2010)
Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats
Ivica Granic et al.
NEUROPHARMACOLOGY (2010)
No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro
Dylan W. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides
Joao P. Lopes et al.
CELL CYCLE (2009)
Cortical Interneurons Require p35/Cdk5 for their Migration and Laminar Organization
Sonja Rakic et al.
CEREBRAL CORTEX (2009)
α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models
Tetyana Duka et al.
FASEB JOURNAL (2009)
Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator
Ryo Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Phosphorylation of Prion Protein at Serine 43 Induces Prion Protein Conformational Change
Paresa N. Giannopoulos et al.
JOURNAL OF NEUROSCIENCE (2009)
Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH2-Terminal Kinase Cascade: Relevance to Neurotoxic Insults in Alzheimer's Disease
Kai-Hui Sun et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
Effect of N-methyl-D-aspartate (NMDA) receptor antagonists on α-synuclein-evoked neuronal nitric oxide synthase activation in the rat brain
Agata Adamczyk et al.
PHARMACOLOGICAL REPORTS (2009)
Making a neuron: Cdk5 in embryonic and adult neurogenesis
Sebastian Jessberger et al.
TRENDS IN NEUROSCIENCES (2009)
Crosstalk between Cdk5 and GSK3 beta: implications for Alzheimer's disease
Olivia Engmann et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2009)
Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors
Shuo Zhang et al.
JOURNAL OF NEUROSCIENCE (2008)
Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2
Zelda H. Cheung et al.
JOURNAL OF NEUROSCIENCE (2008)
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3β mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing
Yi Wen et al.
JOURNAL OF NEUROSCIENCE (2008)
Novel genetic tools reveal Cdk5's major role in golgi fragmentation in Alzheimer's disease
Kai-Hui Sun et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
α-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells
Anna Kazmierczak et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing
Yi Wen et al.
NEURON (2008)
Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease
Daniel Alvira et al.
PARKINSONISM & RELATED DISORDERS (2008)
Akt and CHIP coregulate tau degradation through coordinated interactions
Chad A. Dickey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
Jie Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-beta and Prion peptides: Implications for Alzheimer's disease and Prion-related encephalopathies
Joao P. Lopes et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death
Jong-Hee Lee et al.
JOURNAL OF CELL SCIENCE (2007)
Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation
Ammar H. Hawasli et al.
NATURE NEUROSCIENCE (2007)
Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation
Eyal Avraham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment
Rukhsana Sultana et al.
NEUROCHEMICAL RESEARCH (2007)
Cdk5 modulation of mitogen-activated protein kinase signaling regulates neuronal survival
Ya-Li Zheng et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels
Agata Adamczyk et al.
NEUROREPORT (2006)
P25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid β in vivo
Jonathan C. Cruz et al.
JOURNAL OF NEUROSCIENCE (2006)
Extracellular tau is toxic to neuronal cells
Alberto Gomez-Ramos et al.
FEBS LETTERS (2006)
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation
Florian Plattner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
α-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes -: Relationship to nitric oxide
Agata Adamczyk et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of α-synuclein, in SH-SY5Y neuroblastoma cells
Tetyana Duka et al.
NEUROTOXICITY RESEARCH (2006)
Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease
D Alvira et al.
JOURNAL OF PINEAL RESEARCH (2006)
Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2
PD Smith et al.
JOURNAL OF NEUROSCIENCE (2006)
Soluble β-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses
F Roselli et al.
JOURNAL OF NEUROSCIENCE (2005)
Macroautophagy -: a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
WH Yu et al.
JOURNAL OF CELL BIOLOGY (2005)
A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons
G Morfini et al.
EMBO JOURNAL (2004)
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
PD Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival
BS Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3
M Pérez et al.
BIOCHEMICAL JOURNAL (2003)
Aggregated and monomeric α-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function
H Snyder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
p35/Cdk5 pathway mediates soluble amyloid-β peptide-induced tau phosphorylation in vitro
T Town et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains
HC Tseng et al.
FEBS LETTERS (2002)
Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability
KF Lau et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Cdk5 phosphorylates p53 and regulates its activity
JW Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3
BS Li et al.
EMBO JOURNAL (2002)
β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease
E Masliah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain
A Takashima et al.
NEUROSCIENCE LETTERS (2001)
Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo
M Neystat et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
Y Tanaka et al.
HUMAN MOLECULAR GENETICS (2001)
A cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of cdk5 activity in hippocampal neurons
A Alvarez et al.
EXPERIMENTAL CELL RESEARCH (2001)
Activated Fyn phosphorylates α-synuclein at tyrosine residue 125
T Nakamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains
S Taniguchi et al.
FEBS LETTERS (2001)
Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells
R Nath et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease
M Takahashi et al.
BRAIN RESEARCH (2000)
Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
MK Ahlijanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
